NSE filing, NSE: BETA. Summary written from the filing by ALFA Finder's alert engine.
Beta Drugs Ltd: key numbers
- Share price
- ₹1,849.70
- Market cap
- ₹2,051 Cr
- Revenue (annual)
- ₹384.8 Cr
- Net profit (annual)
- ₹41.48 Cr
- P/E (TTM)
- 39.5×Sector 48.7×
- Promoter holding
- 58.91%-0.19% QoQ
- FII holding
- 1.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Beta Drugs Ltd
All →Beta Drugs Other Announcement
Beta Drugs Limited submitted its quarterly Statement of Deviation or Variation for the preferential issue proceeds, confirming no deviation from the stated objects.
Beta Drugs Earnings Call Transcript: Key Takeaways
Management projects a 20-25% growth trajectory despite Q2 bottlenecks. Recent acquisitions and niche oncology focus underpin expansion strategy.
- Call
- Guides 25% growth
Beta Drugs Investor Presentation: Key Takeaways
Beta Drugs reported H1 FY27 revenue of INR 263 Cr with EBITDA margins expanding to 23.2%. The firm is transitioning from a CMO to a branded specialty oncology powerhouse.
Beta Drugs Q2 FY27 Results: Net Profit ₹185,507,075 Cr, Up 51.8% YoY
Beta Drugs Ltd reported revenue from operations of ₹1,374,887,594 Cr (+33.0% YoY) and net profit of ₹185,507,075 Cr (+51.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹185,507,075 Cr · +51.8% YoY
Beta Drugs Board Meeting Date
Beta Drugs Limited notified the exchange of a board meeting scheduled for 22-Oct-2026 to consider quarterly financial results. The trading window closure was also intimated.
Beta Drugs Annual General Meeting
Beta Drugs Limited conducted its 21st Annual General Meeting on September 30, 2026. Shareholders considered resolutions including financial statement adoption, director re-appointments, and auditor ratification.
Other share pledge announcements
All →Refex Industries Share Pledge
Refex Holding pledged shares to multiple entities, raising encumbered stake to 29.06% of capital. Pledged shares now total 51.37% of promoter holding.
Ginni Filaments Share Pledge
SBICAP Trustee released a pledge over 26,48,300 Ginni Filaments shares, cutting its stake to 9.06%. No cash changed hands in the encumbrance release.
Manipal Health Enterprises Share Pledge
Promoter entity MEMG International India Pvt Ltd released pledges over 72,50,000 and 72,42,951 shares of Manipal Health Enterprises. The 22 October 2026 release eases encumbrances in favour of Vistra ITCL and 360 One Prime.
Camlin Fine Sciences Share Pledge
Camlin Fine Sciences promoter-director Ashish Dandekar created pledges over 13.60 lakh shares worth ₹11.39 Cr. No change in shareholding; total pledged exposure rises for investors to monitor.
- Value
- ₹11.39 Cr
TVS Holdings Share Pledge
Promoter trusts pledged TVS Holdings shares to JM Financial entities as security for credit facilities. The pledge covers 16,75,800 shares, or 8.28% of total share capital.
Paisalo Digital Share Pledge
Equilibrated Venture Cflow, a promoter group entity, pledged 2.98 crore Paisalo shares on October 26, 2026. The pledge secures a Rs.25 Crore third-party loan from Jio Credit.
- Value
- ₹25.00 Cr